Pharmacology of Movement Disorders and Seizures
About this topic
This topic explores the pharmacological management of neurological conditions such as epilepsy, chorea, dystonia, and drug-induced movement disorders, focusing on mechanisms of action, therapeutic uses, and major adverse effects. For Zambian college and university students in medicine, pharmacy, and clinical sciences, understanding drugs like valproate, carbamazepine, benzodiazepines, and antipsychotics is crucial for safe and effective patient care. The content addresses Zambia's healthcare needs by emphasizing rational drug selection, monitoring for toxicity (e.g., hepatotoxicity with valproate), and managing conditions prevalent in local communities. This knowledge is essential for passing pharmacology examinations, making informed therapeutic decisions during clinical attachments, and preparing for professional licensing with bodies like the Health Professions Council of Zambia. It bridges basic neuroscience with clinical therapeutics.
What you'll practise (3 questions)
- Parkinsonism therapy targets dopaminergic neuron loss.
- Levodopa is combined with carbidopa.
- Which drug is a dopamine-receptor agonist?
Answer each question above to see the correct answer and a full explanation.